Biosimilars/follow-on-biologics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Biosimilars/follow-on-biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilars/follow-on-biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilars/follow-on-biologics Overall Market Size
2.1 Global Biosimilars/follow-on-biologics Market Size: 2021 VS 2028
2.2 Global Biosimilars/follow-on-biologics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biosimilars/follow-on-biologics Players in Global Market
3.2 Top Global Biosimilars/follow-on-biologics Companies Ranked by Revenue
3.3 Global Biosimilars/follow-on-biologics Revenue by Companies
3.4 Top 3 and Top 5 Biosimilars/follow-on-biologics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biosimilars/follow-on-biologics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biosimilars/follow-on-biologics Players in Global Market
3.6.1 List of Global Tier 1 Biosimilars/follow-on-biologics Companies
3.6.2 List of Global Tier 2 and Tier 3 Biosimilars/follow-on-biologics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Biosimilars/follow-on-biologics Market Size Markets, 2021 & 2028
4.1.2 Human growth hormone
4.1.3 Erythropoietin
4.1.4 Monoclonal antibodies
4.1.5 Insulin
4.1.6 Interferon
4.1.7 Granulocyte-Colony Stimulating Factor
4.1.8 Others
4.2 By Type - Global Biosimilars/follow-on-biologics Revenue & Forecasts
4.2.1 By Type - Global Biosimilars/follow-on-biologics Revenue, 2017-2022
4.2.2 By Type - Global Biosimilars/follow-on-biologics Revenue, 2023-2028
4.2.3 By Type - Global Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biosimilars/follow-on-biologics Market Size, 2021 & 2028
5.1.2 Blood Disorders
5.1.3 Oncology Diseases
5.1.4 Chronic and Autoimmune Diseases
5.1.5 Growth Hormone Deficiencies
5.1.6 Others
5.2 By Application - Global Biosimilars/follow-on-biologics Revenue & Forecasts
5.2.1 By Application - Global Biosimilars/follow-on-biologics Revenue, 2017-2022
5.2.2 By Application - Global Biosimilars/follow-on-biologics Revenue, 2023-2028
5.2.3 By Application - Global Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Biosimilars/follow-on-biologics Market Size, 2021 & 2028
6.2 By Region - Global Biosimilars/follow-on-biologics Revenue & Forecasts
6.2.1 By Region - Global Biosimilars/follow-on-biologics Revenue, 2017-2022
6.2.2 By Region - Global Biosimilars/follow-on-biologics Revenue, 2023-2028
6.2.3 By Region - Global Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Biosimilars/follow-on-biologics Revenue, 2017-2028
6.3.2 US Biosimilars/follow-on-biologics Market Size, 2017-2028
6.3.3 Canada Biosimilars/follow-on-biologics Market Size, 2017-2028
6.3.4 Mexico Biosimilars/follow-on-biologics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Biosimilars/follow-on-biologics Revenue, 2017-2028
6.4.2 Germany Biosimilars/follow-on-biologics Market Size, 2017-2028
6.4.3 France Biosimilars/follow-on-biologics Market Size, 2017-2028
6.4.4 U.K. Biosimilars/follow-on-biologics Market Size, 2017-2028
6.4.5 Italy Biosimilars/follow-on-biologics Market Size, 2017-2028
6.4.6 Russia Biosimilars/follow-on-biologics Market Size, 2017-2028
6.4.7 Nordic Countries Biosimilars/follow-on-biologics Market Size, 2017-2028
6.4.8 Benelux Biosimilars/follow-on-biologics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Biosimilars/follow-on-biologics Revenue, 2017-2028
6.5.2 China Biosimilars/follow-on-biologics Market Size, 2017-2028
6.5.3 Japan Biosimilars/follow-on-biologics Market Size, 2017-2028
6.5.4 South Korea Biosimilars/follow-on-biologics Market Size, 2017-2028
6.5.5 Southeast Asia Biosimilars/follow-on-biologics Market Size, 2017-2028
6.5.6 India Biosimilars/follow-on-biologics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Biosimilars/follow-on-biologics Revenue, 2017-2028
6.6.2 Brazil Biosimilars/follow-on-biologics Market Size, 2017-2028
6.6.3 Argentina Biosimilars/follow-on-biologics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biosimilars/follow-on-biologics Revenue, 2017-2028
6.7.2 Turkey Biosimilars/follow-on-biologics Market Size, 2017-2028
6.7.3 Israel Biosimilars/follow-on-biologics Market Size, 2017-2028
6.7.4 Saudi Arabia Biosimilars/follow-on-biologics Market Size, 2017-2028
6.7.5 UAE Biosimilars/follow-on-biologics Market Size, 2017-2028
7 Players Profiles
7.1 Novartis (Sandoz)
7.1.1 Novartis (Sandoz) Corporate Summary
7.1.2 Novartis (Sandoz) Business Overview
7.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Major Product Offerings
7.1.4 Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue in Global Market (2017-2022)
7.1.5 Novartis (Sandoz) Key News
7.2 Synthon Pharmaceuticals
7.2.1 Synthon Pharmaceuticals Corporate Summary
7.2.2 Synthon Pharmaceuticals Business Overview
7.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Major Product Offerings
7.2.4 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue in Global Market (2017-2022)
7.2.5 Synthon Pharmaceuticals Key News
7.3 Teva Pharmaceutical Industries
7.3.1 Teva Pharmaceutical Industries Corporate Summary
7.3.2 Teva Pharmaceutical Industries Business Overview
7.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Major Product Offerings
7.3.4 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue in Global Market (2017-2022)
7.3.5 Teva Pharmaceutical Industries Key News
7.4 LG Life Sciences
7.4.1 LG Life Sciences Corporate Summary
7.4.2 LG Life Sciences Business Overview
7.4.3 LG Life Sciences Biosimilars/follow-on-biologics Major Product Offerings
7.4.4 LG Life Sciences Biosimilars/follow-on-biologics Revenue in Global Market (2017-2022)
7.4.5 LG Life Sciences Key News
7.5 Celltrion Biocon
7.5.1 Celltrion Biocon Corporate Summary
7.5.2 Celltrion Biocon Business Overview
7.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Major Product Offerings
7.5.4 Celltrion Biocon Biosimilars/follow-on-biologics Revenue in Global Market (2017-2022)
7.5.5 Celltrion Biocon Key News
7.6 Hospira
7.6.1 Hospira Corporate Summary
7.6.2 Hospira Business Overview
7.6.3 Hospira Biosimilars/follow-on-biologics Major Product Offerings
7.6.4 Hospira Biosimilars/follow-on-biologics Revenue in Global Market (2017-2022)
7.6.5 Hospira Key News
7.7 Merck Serono (Merck)
7.7.1 Merck Serono (Merck) Corporate Summary
7.7.2 Merck Serono (Merck) Business Overview
7.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Major Product Offerings
7.7.4 Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue in Global Market (2017-2022)
7.7.5 Merck Serono (Merck) Key News
7.8 Biogen idec
7.8.1 Biogen idec Corporate Summary
7.8.2 Biogen idec Business Overview
7.8.3 Biogen idec Biosimilars/follow-on-biologics Major Product Offerings
7.8.4 Biogen idec Biosimilars/follow-on-biologics Revenue in Global Market (2017-2022)
7.8.5 Biogen idec Key News
7.9 Genentech (Roche)
7.9.1 Genentech (Roche) Corporate Summary
7.9.2 Genentech (Roche) Business Overview
7.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Major Product Offerings
7.9.4 Genentech (Roche) Biosimilars/follow-on-biologics Revenue in Global Market (2017-2022)
7.9.5 Genentech (Roche) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Biosimilars/follow-on-biologics Market Opportunities & Trends in Global Market
Table 2. Biosimilars/follow-on-biologics Market Drivers in Global Market
Table 3. Biosimilars/follow-on-biologics Market Restraints in Global Market
Table 4. Key Players of Biosimilars/follow-on-biologics in Global Market
Table 5. Top Biosimilars/follow-on-biologics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Biosimilars/follow-on-biologics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Biosimilars/follow-on-biologics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Biosimilars/follow-on-biologics Product Type
Table 9. List of Global Tier 1 Biosimilars/follow-on-biologics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilars/follow-on-biologics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Biosimilars/follow-on-biologics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Biosimilars/follow-on-biologics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Biosimilars/follow-on-biologics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Biosimilars/follow-on-biologics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Biosimilars/follow-on-biologics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Biosimilars/follow-on-biologics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2023-2028
Table 30. Novartis (Sandoz) Corporate Summary
Table 31. Novartis (Sandoz) Biosimilars/follow-on-biologics Product Offerings
Table 32. Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue (US$, Mn), (2017-2022)
Table 33. Synthon Pharmaceuticals Corporate Summary
Table 34. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product Offerings
Table 35. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue (US$, Mn), (2017-2022)
Table 36. Teva Pharmaceutical Industries Corporate Summary
Table 37. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product Offerings
Table 38. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue (US$, Mn), (2017-2022)
Table 39. LG Life Sciences Corporate Summary
Table 40. LG Life Sciences Biosimilars/follow-on-biologics Product Offerings
Table 41. LG Life Sciences Biosimilars/follow-on-biologics Revenue (US$, Mn), (2017-2022)
Table 42. Celltrion Biocon Corporate Summary
Table 43. Celltrion Biocon Biosimilars/follow-on-biologics Product Offerings
Table 44. Celltrion Biocon Biosimilars/follow-on-biologics Revenue (US$, Mn), (2017-2022)
Table 45. Hospira Corporate Summary
Table 46. Hospira Biosimilars/follow-on-biologics Product Offerings
Table 47. Hospira Biosimilars/follow-on-biologics Revenue (US$, Mn), (2017-2022)
Table 48. Merck Serono (Merck) Corporate Summary
Table 49. Merck Serono (Merck) Biosimilars/follow-on-biologics Product Offerings
Table 50. Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue (US$, Mn), (2017-2022)
Table 51. Biogen idec Corporate Summary
Table 52. Biogen idec Biosimilars/follow-on-biologics Product Offerings
Table 53. Biogen idec Biosimilars/follow-on-biologics Revenue (US$, Mn), (2017-2022)
Table 54. Genentech (Roche) Corporate Summary
Table 55. Genentech (Roche) Biosimilars/follow-on-biologics Product Offerings
Table 56. Genentech (Roche) Biosimilars/follow-on-biologics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Biosimilars/follow-on-biologics Segment by Type in 2021
Figure 2. Biosimilars/follow-on-biologics Segment by Application in 2021
Figure 3. Global Biosimilars/follow-on-biologics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biosimilars/follow-on-biologics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biosimilars/follow-on-biologics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biosimilars/follow-on-biologics Revenue in 2021
Figure 8. By Type - Global Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
Figure 12. US Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
Figure 16. Germany Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 17. France Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
Figure 24. China Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 28. India Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
Figure 30. Brazil Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
Figure 33. Turkey Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. LG Life Sciences Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celltrion Biocon Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Hospira Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Biogen idec Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Genentech (Roche) Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)